Developing BMPR2 Inhibitors and Methods of Treating Cancer and Cognitive Defects
Principal Investigator: John Langenfeld
Affiliation: Co-Director, Thoracic Oncology Program, Thoracic Surgeon Rutgers Cancer Institute of New Jersey
Amount: $200,000
Research Sponsor: ROI HealthAdvance